114 related articles for article (PubMed ID: 7679378)
1. In vitro combined effects of human interferons and interleukin-2 on natural cell-mediated cytotoxicity.
Fuggetta MP; Aquino A; Pepponi R; D'Atri S; Lanzilli G; Bonmassar E; Graziani G
Int J Immunopharmacol; 1993 Jan; 15(1):1-10. PubMed ID: 7679378
[TBL] [Abstract][Full Text] [Related]
2. Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells.
Brunda MJ; Tarnowski D; Davatelis V
Int J Cancer; 1986 May; 37(5):787-93. PubMed ID: 2422129
[TBL] [Abstract][Full Text] [Related]
3. Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2).
Hank JA; Surfus JE; Gan J; Jaeger P; Gillies SD; Reisfeld RA; Sondel PM
Clin Cancer Res; 1996 Dec; 2(12):1951-9. PubMed ID: 9816154
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroids inhibit the generation of lymphokine-activated killer activity in vitro.
McVicar DW; Merchant RE; Merchant LH; Young HF
Cancer Immunol Immunother; 1989; 29(3):211-8. PubMed ID: 2499421
[TBL] [Abstract][Full Text] [Related]
5. Interferon-Beta combined with interleukin-2 restores human natural cytotoxicity impaired in vitro by ionizing radiations.
Franzese O; Tricarico M; Starace G; Pepponi R; Bonmassar L; Cottarelli A; Fuggetta MP
J Interferon Cytokine Res; 2013 Jun; 33(6):308-18. PubMed ID: 23421371
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of human natural cytotoxicity by Plasmodium falciparum antigen activated lymphocytes.
Theander TG; Pedersen BK; Bygbjerg IC; Jepsen S; Larsen PB; Kharazmi A
Acta Trop; 1987 Dec; 44(4):415-22. PubMed ID: 2449809
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of an acyltripeptide, FK565, on NK-cell activity, LAK-cell generation and cytokine production by human mononuclear cells.
Wang YL; Whiteside TL; Friberg D; Herberman RB
Immunopharmacology; 1989; 17(3):175-85. PubMed ID: 2504680
[TBL] [Abstract][Full Text] [Related]
8. Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity.
Brooks B; Rees RC
Clin Exp Immunol; 1988 Nov; 74(2):162-5. PubMed ID: 3265652
[TBL] [Abstract][Full Text] [Related]
9. Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro.
Higuchi CM; Thompson JA; Lindgren CG; Gillis S; Widmer MB; Kern DE; Fefer A
Cancer Res; 1989 Dec; 49(23):6487-92. PubMed ID: 2479463
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells.
Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT
Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875
[TBL] [Abstract][Full Text] [Related]
11. Effects of interleukin 4 upon human tumoricidal cells obtained from patients bearing solid tumors.
Jadus MR; Good RW; Crumpacker DB; Yannelli JR
J Leukoc Biol; 1991 Feb; 49(2):139-51. PubMed ID: 1991997
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cells.
De Filippi R; Prete SP; Giuliani A; Silvi E; Yamaue H; Nieroda CA; Greiner JW; De Vecchis L; Bonmassar E
Anticancer Res; 1994; 14(5A):1767-73. PubMed ID: 7847809
[TBL] [Abstract][Full Text] [Related]
13. Persistent augmentation of natural-killer- and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance dose.
Palmer PA; Scharenberg JG; von Blomberg BM; Stam AG; Meijer CJ; Roest GJ; Franks CR; Scheper RJ
Cancer Immunol Immunother; 1994 Jul; 39(1):34-40. PubMed ID: 8044824
[TBL] [Abstract][Full Text] [Related]
14. TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2.
Favrot M; Combaret V; Blay JY; Capdeville R; Zhou DC; Clapisson G; Chouaib S; Franks CR; Philip T
Eur Cytokine Netw; 1990; 1(4):221-7. PubMed ID: 2104243
[TBL] [Abstract][Full Text] [Related]
15. Restoring Natural Killer Cell Cytotoxicity After Hyperthermia Alone or Combined with Radiotherapy.
Hietanen T; Kapanen M; Kellokumpu-Lehtinen PL
Anticancer Res; 2016 Feb; 36(2):555-63. PubMed ID: 26851009
[TBL] [Abstract][Full Text] [Related]
16. Effects of diheptyldiselenide (DDS) on human tumor cell lines and on peripheral blood mononuclear cells.
Tentori L; Prete SP; Pepponi R
J Chemother; 1993 Oct; 5(5):325-33. PubMed ID: 8106907
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic activity of NK cells against SW-756 squamous cervical carcinoma cell line: role of interferons alpha and gamma and CD54 adhesion molecule in oncolysis.
Cristoforoni PM; Lotzová E; Cook KR; Chuang LT; Morris M; Grossi CE; Wharton JT
Gynecol Oncol; 1994 Mar; 52(3):365-72. PubMed ID: 7512522
[TBL] [Abstract][Full Text] [Related]
18. IL-2-activated cord blood mononuclear cells.
Derzic S; Slone V; Sender L
Cytotherapy; 2005; 7(5):408-16. PubMed ID: 16236630
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of lymphokine-activated killer cell-mediated cytotoxicity by phorbol ester.
Nishimura T; Burakoff SJ; Herrmann SH
J Immunol; 1989 Mar; 142(6):2155-61. PubMed ID: 2646377
[TBL] [Abstract][Full Text] [Related]
20. Synergism between alpha-interferon and interleukin-2-activated killer cells: in vitro studies.
Di Raimondo F; LaPushin R; Hersh EM
Acta Haematol; 1987; 78 Suppl 1():77-83. PubMed ID: 3124452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
